APO Research
Talk to an analyst

APO RESEARCH · REPORT

Milrinone Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Milrinone Injection Market Analysis and Forecast 2026-2032

30 December 2025193 pages

Choose your research edition.

Industry ResearchMilrinone Injection Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Milrinone Injection Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Milrinone Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Milrinone Injection Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Milrinone Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Milrinone Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Milrinone Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Milrinone Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Milrinone Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Milrinone Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Milrinone Injection include Haini, NJCTTQ, Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd, LUNANLIKANG, SaiLong and PKU HealthCare Corp,.Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Milrinone Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Milrinone Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Milrinone Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Milrinone Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Milrinone Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Milrinone Injection sales, projected growth trends, production technology, application and end-user industry.

Milrinone Injection Segment by Company

Haini

NJCTTQ

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

LUNANLIKANG

SaiLong

PKU HealthCare Corp,.Ltd.

Milrinone Injection Segment by Type

0.98

0.99

Others

Milrinone Injection Segment by Application

Medical

Others

Milrinone Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Milrinone Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Milrinone Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Milrinone Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Milrinone Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Milrinone Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Milrinone Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Milrinone Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.98 Major Manufacturers Table 3. 0.99 Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Milrinone Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Medical Major Manufacturers Table 7. Others Major Manufacturers Table 8. Milrinone Injection Industry Trends Table 9. Milrinone Injection Industry Drivers Table 10. Milrinone Injection Industry Opportunities and Challenges Table 11. Milrinone Injection Industry Restraints Table 12. Global Milrinone Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Milrinone Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Milrinone Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Milrinone Injection Revenue Market Share by Region (2021-2026) Table 16. Global Milrinone Injection Revenue Market Share by Region (2027-2032) Table 17. Global Milrinone Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Milrinone Injection Sales by Region (2021-2026) & (K Units) Table 19. Global Milrinone Injection Sales by Region (2027-2032) & (K Units) Table 20. Global Milrinone Injection Sales Market Share by Region (2021-2026) Table 21. Global Milrinone Injection Sales Market Share by Region (2027-2032) Table 22. Global Milrinone Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Milrinone Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Milrinone Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Milrinone Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Milrinone Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Milrinone Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Milrinone Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Milrinone Injection Manufacturers, Product Type & Application Table 30. Global Milrinone Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Milrinone Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Milrinone Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Milrinone Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Milrinone Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Milrinone Injection Revenue Market Share by Type (2021-2026) Table 37. Global Milrinone Injection Revenue Market Share by Type (2027-2032) Table 38. Global Milrinone Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Milrinone Injection Sales by Type (2021-2026) & (K Units) Table 40. Global Milrinone Injection Sales by Type (2027-2032) & (K Units) Table 41. Global Milrinone Injection Sales Market Share by Type (2021-2026) Table 42. Global Milrinone Injection Sales Market Share by Type (2027-2032) Table 43. Global Milrinone Injection Price by Type (2021-2026) & (US$/Unit) Table 44. Global Milrinone Injection Price by Type (2027-2032) & (US$/Unit) Table 45. Global Milrinone Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Milrinone Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Milrinone Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Milrinone Injection Revenue Market Share by Application (2021-2026) Table 49. Global Milrinone Injection Revenue Market Share by Application (2027-2032) Table 50. Global Milrinone Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Milrinone Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Milrinone Injection Sales by Application (2027-2032) & (K Units) Table 53. Global Milrinone Injection Sales Market Share by Application (2021-2026) Table 54. Global Milrinone Injection Sales Market Share by Application (2027-2032) Table 55. Global Milrinone Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Milrinone Injection Price by Application (2027-2032) & (US$/Unit) Table 57. Haini Company Information Table 58. Haini Business Overview Table 59. Haini Milrinone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Haini Milrinone Injection Product Portfolio Table 61. Haini Recent Development Table 62. NJCTTQ Company Information Table 63. NJCTTQ Business Overview Table 64. NJCTTQ Milrinone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. NJCTTQ Milrinone Injection Product Portfolio Table 66. NJCTTQ Recent Development Table 67. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Company Information Table 68. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Business Overview Table 69. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Milrinone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Milrinone Injection Product Portfolio Table 71. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Recent Development Table 72. LUNANLIKANG Company Information Table 73. LUNANLIKANG Business Overview Table 74. LUNANLIKANG Milrinone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. LUNANLIKANG Milrinone Injection Product Portfolio Table 76. LUNANLIKANG Recent Development Table 77. SaiLong Company Information Table 78. SaiLong Business Overview Table 79. SaiLong Milrinone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. SaiLong Milrinone Injection Product Portfolio Table 81. SaiLong Recent Development Table 82. PKU HealthCare Corp,.Ltd. Company Information Table 83. PKU HealthCare Corp,.Ltd. Business Overview Table 84. PKU HealthCare Corp,.Ltd. Milrinone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. PKU HealthCare Corp,.Ltd. Milrinone Injection Product Portfolio Table 86. PKU HealthCare Corp,.Ltd. Recent Development Table 87. North America Milrinone Injection Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Milrinone Injection Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Milrinone Injection Sales by Type (2021-2026) & (K Units) Table 90. North America Milrinone Injection Sales by Type (2027-2032) & (K Units) Table 91. North America Milrinone Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 92. North America Milrinone Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 93. North America Milrinone Injection Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Milrinone Injection Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Milrinone Injection Sales by Application (2021-2026) & (K Units) Table 96. North America Milrinone Injection Sales by Application (2027-2032) & (K Units) Table 97. North America Milrinone Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 98. North America Milrinone Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 99. North America Milrinone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Milrinone Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Milrinone Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Milrinone Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 103. North America Milrinone Injection Sales by Country (2021-2026) & (K Units) Table 104. North America Milrinone Injection Sales by Country (2027-2032) & (K Units) Table 105. North America Milrinone Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 106. North America Milrinone Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 107. United States Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 108. Canada Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 109. Europe Milrinone Injection Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Milrinone Injection Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Milrinone Injection Sales by Type (2021-2026) & (K Units) Table 112. Europe Milrinone Injection Sales by Type (2027-2032) & (K Units) Table 113. Europe Milrinone Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 114. Europe Milrinone Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 115. Europe Milrinone Injection Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Milrinone Injection Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Milrinone Injection Sales by Application (2021-2026) & (K Units) Table 118. Europe Milrinone Injection Sales by Application (2027-2032) & (K Units) Table 119. Europe Milrinone Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 120. Europe Milrinone Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 121. Europe Milrinone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Milrinone Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Milrinone Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Milrinone Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. Europe Milrinone Injection Sales by Country (2021-2026) & (K Units) Table 126. Europe Milrinone Injection Sales by Country (2027-2032) & (K Units) Table 127. Europe Milrinone Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 128. Europe Milrinone Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 129. Germany Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 130. France Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 131. U.K. Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 132. Italy Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 133. Netherlands Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 134. China Milrinone Injection Revenue by Type (2021-2026) & (US$ Million) Table 135. China Milrinone Injection Revenue by Type (2027-2032) & (US$ Million) Table 136. China Milrinone Injection Sales by Type (2021-2026) & (K Units) Table 137. China Milrinone Injection Sales by Type (2027-2032) & (K Units) Table 138. China Milrinone Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 139. China Milrinone Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 140. China Milrinone Injection Revenue by Application (2021-2026) & (US$ Million) Table 141. China Milrinone Injection Revenue by Application (2027-2032) & (US$ Million) Table 142. China Milrinone Injection Sales by Application (2021-2026) & (K Units) Table 143. China Milrinone Injection Sales by Application (2027-2032) & (K Units) Table 144. China Milrinone Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 145. China Milrinone Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Asia Milrinone Injection Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Milrinone Injection Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Milrinone Injection Sales by Type (2021-2026) & (K Units) Table 149. Asia Milrinone Injection Sales by Type (2027-2032) & (K Units) Table 150. Asia Milrinone Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Asia Milrinone Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Asia Milrinone Injection Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Milrinone Injection Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Milrinone Injection Sales by Application (2021-2026) & (K Units) Table 155. Asia Milrinone Injection Sales by Application (2027-2032) & (K Units) Table 156. Asia Milrinone Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Asia Milrinone Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Milrinone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Milrinone Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Milrinone Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Milrinone Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Asia Milrinone Injection Sales by Country (2021-2026) & (K Units) Table 163. Asia Milrinone Injection Sales by Country (2027-2032) & (K Units) Table 164. Asia Milrinone Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Asia Milrinone Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Japan Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 167. South Korea Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 168. India Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 169. Australia Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 170. China Taiwan Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Milrinone Injection Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Milrinone Injection Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Milrinone Injection Sales by Type (2021-2026) & (K Units) Table 175. SAMEA Milrinone Injection Sales by Type (2027-2032) & (K Units) Table 176. SAMEA Milrinone Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 177. SAMEA Milrinone Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 178. SAMEA Milrinone Injection Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Milrinone Injection Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Milrinone Injection Sales by Application (2021-2026) & (K Units) Table 181. SAMEA Milrinone Injection Sales by Application (2027-2032) & (K Units) Table 182. SAMEA Milrinone Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 183. SAMEA Milrinone Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 184. SAMEA Milrinone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Milrinone Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Milrinone Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Milrinone Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. SAMEA Milrinone Injection Sales by Country (2021-2026) & (K Units) Table 189. SAMEA Milrinone Injection Sales by Country (2027-2032) & (K Units) Table 190. SAMEA Milrinone Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 191. SAMEA Milrinone Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Brazil Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 193. Argentina Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 194. Chile Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 195. Colombia Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 196. Peru Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 198. Israel Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 199. UAE Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 200. Turkey Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 201. Iran Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 202. Egypt Milrinone Injection Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Milrinone Injection Distributors List Table 206. Milrinone Injection Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Milrinone Injection Image Figure 2. Global Milrinone Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Milrinone Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.98 Image Figure 5. 0.99 Image Figure 6. Others Image Figure 7. Global Milrinone Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Milrinone Injection Market Size Share 2021 VS 2025 VS 2032 Figure 9. Medical Image Figure 10. Others Image Figure 11. Global Milrinone Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Milrinone Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Milrinone Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Milrinone Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Milrinone Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Milrinone Injection Sales (2021-2032) & (K Units) Figure 17. Global Milrinone Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Milrinone Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Milrinone Injection Sales YoY (2021-2032) & (K Units) Figure 20. Europe Milrinone Injection Sales YoY (2021-2032) & (K Units) Figure 21. China Milrinone Injection Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Milrinone Injection Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Milrinone Injection Sales YoY (2021-2032) & (K Units) Figure 24. Global Milrinone Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Milrinone Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Milrinone Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Milrinone Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Milrinone Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Milrinone Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Milrinone Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Milrinone Injection Sales Market Share by Type (2021-2032) Figure 33. Global Milrinone Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Milrinone Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Milrinone Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Milrinone Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Milrinone Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Milrinone Injection Sales Market Share by Application (2021-2032) Figure 39. North America Milrinone Injection Revenue Share by Type (2021-2032) Figure 40. North America Milrinone Injection Sales Share by Type (2021-2032) Figure 41. North America Milrinone Injection Revenue Share by Application (2021-2032) Figure 42. North America Milrinone Injection Sales Share by Application (2021-2032) Figure 43. North America Milrinone Injection Revenue Share by Country (2021-2032) Figure 44. North America Milrinone Injection Sales Share by Country (2021-2032) Figure 45. Europe Milrinone Injection Revenue Share by Type (2021-2032) Figure 46. Europe Milrinone Injection Sales Share by Type (2021-2032) Figure 47. Europe Milrinone Injection Revenue Share by Application (2021-2032) Figure 48. Europe Milrinone Injection Sales Share by Application (2021-2032) Figure 49. Europe Milrinone Injection Revenue Share by Country (2021-2032) Figure 50. Europe Milrinone Injection Sales Share by Country (2021-2032) Figure 51. China Milrinone Injection Revenue Share by Type (2021-2032) Figure 52. China Milrinone Injection Sales Share by Type (2021-2032) Figure 53. China Milrinone Injection Revenue Share by Application (2021-2032) Figure 54. China Milrinone Injection Sales Share by Application (2021-2032) Figure 55. Asia Milrinone Injection Revenue Share by Type (2021-2032) Figure 56. Asia Milrinone Injection Sales Share by Type (2021-2032) Figure 57. Asia Milrinone Injection Revenue Share by Application (2021-2032) Figure 58. Asia Milrinone Injection Sales Share by Application (2021-2032) Figure 59. Asia Milrinone Injection Revenue Share by Country (2021-2032) Figure 60. Asia Milrinone Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Milrinone Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Milrinone Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Milrinone Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Milrinone Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Milrinone Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Milrinone Injection Sales Share by Country (2021-2032) Figure 67. Milrinone Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Milrinone Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 0.98
  • 0.99
  • Others
Applications
  • Medical
  • Others
Companies covered
  • Haini
  • NJCTTQ
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd
  • LUNANLIKANG
  • SaiLong
  • PKU HealthCare Corp,.Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Milrinone Injection Market by Type
  3. 1.2.1 Global Milrinone Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.98
  5. 1.2.3 0.99
  6. 1.2.4 Others
  7. 1.3 Milrinone Injection Market by Application
  8. 1.3.1 Global Milrinone Injection Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Medical
  10. 1.3.3 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Milrinone Injection Market Dynamics
  1. 2.1 Milrinone Injection Industry Trends
  2. 2.2 Milrinone Injection Industry Drivers
  3. 2.3 Milrinone Injection Industry Opportunities and Challenges
  4. 2.4 Milrinone Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Milrinone Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Milrinone Injection Revenue by Region
  3. 3.2.1 Global Milrinone Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Milrinone Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Milrinone Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Milrinone Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Milrinone Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Milrinone Injection Sales by Region
  9. 3.4.1 Global Milrinone Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Milrinone Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Milrinone Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Milrinone Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Milrinone Injection Revenue by Manufacturers
  2. 4.1.1 Global Milrinone Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Milrinone Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Milrinone Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Milrinone Injection Sales by Manufacturers
  6. 4.2.1 Global Milrinone Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Milrinone Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Milrinone Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Milrinone Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Milrinone Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Milrinone Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Milrinone Injection Manufacturers, Product Type & Application
  13. 4.7 Global Milrinone Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Milrinone Injection Market CR5 and HHI
  16. 4.8.2 2025 Milrinone Injection Tier 1, Tier 2, and Tier 3
5 Milrinone Injection Market by Type
  1. 5.1 Global Milrinone Injection Revenue by Type
  2. 5.1.1 Global Milrinone Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Milrinone Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Milrinone Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Milrinone Injection Sales by Type
  6. 5.2.1 Global Milrinone Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Milrinone Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Milrinone Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Milrinone Injection Price by Type
6 Milrinone Injection Market by Application
  1. 6.1 Global Milrinone Injection Revenue by Application
  2. 6.1.1 Global Milrinone Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Milrinone Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Milrinone Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Milrinone Injection Sales by Application
  6. 6.2.1 Global Milrinone Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Milrinone Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Milrinone Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Milrinone Injection Price by Application
7 Company Profiles
  1. 7.1 Haini
  2. 7.1.1 Haini Company Information
  3. 7.1.2 Haini Business Overview
  4. 7.1.3 Haini Milrinone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Haini Milrinone Injection Product Portfolio
  6. 7.1.5 Haini Recent Developments
  7. 7.2 NJCTTQ
  8. 7.2.1 NJCTTQ Company Information
  9. 7.2.2 NJCTTQ Business Overview
  10. 7.2.3 NJCTTQ Milrinone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 NJCTTQ Milrinone Injection Product Portfolio
  12. 7.2.5 NJCTTQ Recent Developments
  13. 7.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd
  14. 7.3.1 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Company Information
  15. 7.3.2 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Business Overview
  16. 7.3.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Milrinone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Milrinone Injection Product Portfolio
  18. 7.3.5 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Recent Developments
  19. 7.4 LUNANLIKANG
  20. 7.4.1 LUNANLIKANG Company Information
  21. 7.4.2 LUNANLIKANG Business Overview
  22. 7.4.3 LUNANLIKANG Milrinone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 LUNANLIKANG Milrinone Injection Product Portfolio
  24. 7.4.5 LUNANLIKANG Recent Developments
  25. 7.5 SaiLong
  26. 7.5.1 SaiLong Company Information
  27. 7.5.2 SaiLong Business Overview
  28. 7.5.3 SaiLong Milrinone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 SaiLong Milrinone Injection Product Portfolio
  30. 7.5.5 SaiLong Recent Developments
  31. 7.6 PKU HealthCare Corp,.Ltd.
  32. 7.6.1 PKU HealthCare Corp,.Ltd. Company Information
  33. 7.6.2 PKU HealthCare Corp,.Ltd. Business Overview
  34. 7.6.3 PKU HealthCare Corp,.Ltd. Milrinone Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 PKU HealthCare Corp,.Ltd. Milrinone Injection Product Portfolio
  36. 7.6.5 PKU HealthCare Corp,.Ltd. Recent Developments
8 North America
  1. 8.1 North America Milrinone Injection Market Size by Type
  2. 8.1.1 North America Milrinone Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Milrinone Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Milrinone Injection Price by Type (2021-2032)
  5. 8.2 North America Milrinone Injection Market Size by Application
  6. 8.2.1 North America Milrinone Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Milrinone Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Milrinone Injection Price by Application (2021-2032)
  9. 8.3 North America Milrinone Injection Market Size by Country
  10. 8.3.1 North America Milrinone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Milrinone Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Milrinone Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Milrinone Injection Market Size by Type
  2. 9.1.1 Europe Milrinone Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Milrinone Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Milrinone Injection Price by Type (2021-2032)
  5. 9.2 Europe Milrinone Injection Market Size by Application
  6. 9.2.1 Europe Milrinone Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Milrinone Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Milrinone Injection Price by Application (2021-2032)
  9. 9.3 Europe Milrinone Injection Market Size by Country
  10. 9.3.1 Europe Milrinone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Milrinone Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Milrinone Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Milrinone Injection Market Size by Type
  2. 10.1.1 China Milrinone Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Milrinone Injection Sales by Type (2021-2032)
  4. 10.1.3 China Milrinone Injection Price by Type (2021-2032)
  5. 10.2 China Milrinone Injection Market Size by Application
  6. 10.2.1 China Milrinone Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Milrinone Injection Sales by Application (2021-2032)
  8. 10.2.3 China Milrinone Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Milrinone Injection Market Size by Type
  2. 11.1.1 Asia Milrinone Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Milrinone Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Milrinone Injection Price by Type (2021-2032)
  5. 11.2 Asia Milrinone Injection Market Size by Application
  6. 11.2.1 Asia Milrinone Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Milrinone Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Milrinone Injection Price by Application (2021-2032)
  9. 11.3 Asia Milrinone Injection Market Size by Country
  10. 11.3.1 Asia Milrinone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Milrinone Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Milrinone Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Milrinone Injection Market Size by Type
  2. 12.1.1 SAMEA Milrinone Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Milrinone Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Milrinone Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Milrinone Injection Market Size by Application
  6. 12.2.1 SAMEA Milrinone Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Milrinone Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Milrinone Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Milrinone Injection Market Size by Country
  10. 12.3.1 SAMEA Milrinone Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Milrinone Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Milrinone Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Milrinone Injection Value Chain Analysis
  2. 13.1.1 Milrinone Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Milrinone Injection Production Mode & Process
  6. 13.2 Milrinone Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Milrinone Injection Distributors
  9. 13.2.3 Milrinone Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst